Pharsight

Drugs that contain Avanafil

1. Stendra patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6656935 METUCHEN PHARMS Aromatic nitrogen-containing 6-membered cyclic compounds
Apr, 2025

(1 year, 6 days from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7501409 METUCHEN PHARMS Preparations for oral administration
May, 2023

(11 months ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-282) Oct 18, 2025
New Dosing Schedule(D-140) Sep 17, 2017
New Chemical Entity Exclusivity(NCE) Apr 27, 2017

NCE-1 date: 27 April, 2016

Market Authorisation Date: 27 April, 2012

Treatment: Treatment of erectile dysfunction

Dosage: TABLET;ORAL

How can I launch a generic of STENDRA before it's drug patent expiration?
More Information on Dosage

STENDRA family patents

Family Patents